Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

Be the first to review this product

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

Summary

Point-of-care testing (POCT), as known as bedside/near-patient testing is one of the most rapidly growing areas...
You can choose to pay by purchase order during checkout

Availability: In stock

$5,995.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

Summary

Point-of-care testing (POCT), as known as bedside/near-patient testing is one of the most rapidly growing areas in IVD. Systems that are categorized as POC include the following -
- Disposable systems or devices, which vary from reagent test strips for a single analyte to multi-analyte reagent strips
- Small analyzers, usually hand-held devices
- Desktop analyzers are larger and include systems designed for use in clinics or small laboratories.

POCT may be performed in a variety of locations such as in secondary care including emergency departments, ambulance service, hospital wards, and intensive treatment units; and increasingly in the community and primary care including general practice (GP), health and community centers.
- $2 billion in annual global sales and growth rate of 5.3% during the forecast period; the emerging markets: China, India and Brazil, are expected to show the fastest growth.
- A number of factors, such as the increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home-based POC devices, expansion of test menu, and advancements in molecular testing and lab-on-chip technology are stimulating the demand for POC testing.
- The rate of POC testing adoption will be moderated by the requirement for regulatory compliance, the pressure to control cost, and the need to demonstrate clear clinical-cost benefits of POC testing over central laboratory testing.

Highlights

Key Questions Answered

- What is the current and future POC diagnostics market outlook in the developed and emerging markets? What trends are affecting the global market?
- What is the competitive landscape and market share of major players in the POC space across different regions?
- What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the POC tests currently on the market? How will emerging technologies such as molecular POC assays fulfil these unmet needs?
- What are the key factors influencing a physician to use POC tests? What is physician perception and market outlook of POC devices?
- What are the challenges and barriers that have hindered widespread adoption of POC devices?

Scope

- Competitive assessment: Currently marketed POC products and evolving competitive landscape
- In-depth analysis of unmet needs and adoption trends of different POC devices
- Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
- Pipeline analysis: Emerging products and technologies.
- Annualized total POC diagnostics market revenue by segment and market outlooks by country from 2012-2021.
- Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
- Develop business strategies by understanding the trends shaping and driving the global market
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Track device sales in the global market from 2012-2021
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 186
Publication date 1 Mar 2016
Table of contents 1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 12
1.2 List of Figures 16
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 18
3 Industry Overview 19
3.1 POC Diagnostics Overview 19
3.2 Test Trends 21
3.2.1 Cardiac Markers POC Testing 21
3.2.2 Female Fertility and Pregnancy POC Testing 24
3.3 Mergers, Acquisitions, and Key Partnerships 29
4 Unmet Needs 33
4.1 Detection of Multiple Analytes 33
4.2 Sensitivity of Lateral Flow Technology 33
4.3 Analytical Quality 35
4.4 Markers for Myocardial Ischemia 35
4.5 Data Management 36
4.6 POC Diagnostics to Reduce Usage of Antibiotics 37
4.7 Cost-Effectiveness and Reimbursement 38
4.8 Gap between Physicians and Manufacturers 39
5 Market Drivers and Barriers 40
5.1 Drivers 40
5.1.1 Fast Turnaround Time 40
5.1.2 POC Molecular Testing Driving Infectious Disease POCT 40
5.1.3 Increasing Adoption of Cardiac Marker POCT 41
5.1.4 Expansion POC Testing Menu 42
5.1.5 Expansion of the Home-Testing Market 43
5.1.6 CLIA Waived Status for POCT 43
5.1.7 Rising Prevalence of Diseases 44
5.2 Barriers 44
5.2.1 Management of POCT 44
5.2.2 Competition with Laboratory Tests 45
5.2.3 Regulatory Compliance 46
5.2.4 Medical Device Excise Tax 47
6 Competitive Assessment 48
6.1 Company Share Analysis 48
6.1.1 Global 48
6.1.2 US 49
6.1.3 Europe 50
6.1.4 Asia-Pacific 51
6.2 Trends in Corporate Strategy 52
6.3 Major Players 53
6.3.1 Abbott Diagnostics 53
6.3.2 Akers Bioscience 56
6.3.3 Alere 59
6.3.4 Beckman Coulter 64
6.3.5 BioMerieux 66
6.3.6 Chembio Diagnostics 69
6.3.7 EKF Diagnostics 72
6.3.8 Meridian Bioscience 75
6.3.9 OraSure Technologies 79
6.3.10 Quidel 82
6.3.11 Radiometer Medical 86
6.3.12 Response Biomedical 89
6.3.13 Roche Diagnostics 93
6.3.14 Siemens Healthcare 97
6.3.15 Trinity Biotech 100
6.3.16 Other Companies 104
7 Pipeline Assessment 116
7.1 Overview 116
7.2 Pipeline Profiles 117
7.2.1 Cardiac Markers POCT 117
7.2.2 Female Fertility and Pregnancy POCT 118
7.2.3 Hematology POCT 118
7.2.4 Infectious Disease POCT 119
7.2.5 Immunochemistry POCT Analyzers 125
8 Market Outlook 126
8.1 By Market Segment 126
8.1.1 Global Overview 126
8.1.2 Cardiac Markers POCT 128
8.1.3 Female Fertility and Pregnancy POCT 130
8.1.4 Hematology POCT 132
8.1.5 Infectious Disease POCT 133
8.1.6 Immunochemistry POCT Analyzers 134
8.2 By Geography 136
8.2.1 Global Overview 136
8.2.2 US 139
8.2.3 France 141
8.2.4 Germany 144
8.2.5 Italy 146
8.2.6 Spain 150
8.2.7 UK 152
8.2.8 Japan 156
8.2.9 China 158
8.2.10 India 161
8.2.11 Brazil 164
9 Appendix 168
9.1 Bibliography 168
9.2 Abbreviations 172
9.3 Report Methodology 177
9.3.1 Overview 177
9.3.2 Coverage 177
9.3.3 Secondary Research 177
9.3.4 Forecasting Methodology 178
9.3.5 Primary Research

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register